Erratum to "The yeast model suggests the use of short peptides derived from mt LeuRS for the therapy of diseases due to mutations in several mt tRNAs" [Biochim. Biophy. Acta 1843 (2014) The publisher regrets that due to an error during production, the published versions of Tables 1, 2, and 3 in the article referenced above were not formatted correctly. The corrected tables are given below.
Aminoacylation defect
[17]
No tRNAs -- No tRNAs --
[18]
GLN C6T
[40]
Structural and aminoacylation defects
+ indicates growth similar to wild type; -indicates absence of growth; +/-indicates partial growth.
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3′ end processing
[27]
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Ternary complex formation
The publisher would like to apologise for any inconvenience caused. 
tRNA aminoacylated by Class I aaRS
[7]
LEU A14G --
tRNA aminoacylated by Class II aaRS
"Cterm" is the carboxy-terminal domain of the human mt ValRS and IleRS aligned with the suppressing Cterm domain of human mt LeuRS. + indicates growth similar to wild type; -indicates absence of growth; +/-indicates partial growth.
